Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Diabetes Research and Clinical Practice|March 21, 2017
Depressive states among adults with diabetes: Findings from the National Health and Nutrition Examination Survey, 2007-2012Juan Rafael Albertorio-Diaz, Mark S Eberhardt, Maria Oquendo, et al.
BMC Cancer|May 21, 2011
Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver diseaseFrank Tacke, Nicolas Kanig, Abdelaziz En-Nia, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 1995
Active site topology and reaction mechanism of GTP cyclohydrolase IH Nar, R Huber, G Auerbach, et al.
Medicine and Science in Sports and Exercise|June 11, 2021
US Population-referenced Percentiles for Wrist-Worn Accelerometer-derived ActivityBritni R Belcher, Dana L Wolff-Hughes, Erin E Dooley, et al.
American Journal of Epidemiology|May 25, 2013
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994Mariana Lazo, Ruben Hernaez, Mark S Eberhardt, et al.
BMC Cancer|January 22, 2014
High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different originFrank Tacke, Oliver Galm, Nicolas Kanig, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adultsThomas P Erlinger, Michelle E Tarver-Carr, Neil R Powe, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2002
Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factorsMichelle E Tarver-Carr, Neil R Powe, Mark S Eberhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2012
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancerC F Verschraegen, S Czok, C Y Muller, et al.
Pageof 13